Industry Focus
Healthcare: Thalidomide's Present-Day Legacy
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:19:58
- Mas informaciones
Informações:
Sinopsis
Extreme birth defects associated with a popular anti-anxiety medicine from the 1960's had a lasting impact on today's healthcare policy -- and the drug is still a major part of Celgene's cancer portfolio.
